Sivik Global Healthcare’s Maravai LifeSciences MRVI Stock Holding History

Sivik Global Healthcare’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-140,000	Closed	-$763K	–	41
2024 Q4	$763K	Sell	140,000 -285,000	-67%	-$1.83M	0.4%	38
2024 Q3	$3.53M	Sell	425,000 -25,000	-6%	-$216K	1.5%	29
2024 Q2	$3.22M	Buy	450,000 +85,000	+23%	+$734K	1.16%	34
2024 Q1	$3.17M	Buy	365,000 +159,759	+78%	+$1.08M	0.74%	39
2023 Q4	$1.34M	Buy	+205,241	New	+$1.33M	0.56%	39
2021 Q4	–	Sell	-75,000	Closed	-$3.68M	–	53
2021 Q3	$3.68M	Buy	+75,000	New	+$3.66M	0.88%	38

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sivik Global Healthcare's MRVI Position: Q1 2025 in Review

Sivik Global Healthcare sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 140,000 shares — an estimated $763K sold.

Sivik Global Healthcare first reported a position in MRVI in Q3 2021 and held it in 6 quarters. The position peaked at $3.68M in Q3 2021. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

Sivik Global Healthcare reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
Sivik Global Healthcare sold 140,000 Maravai LifeSciences shares in Q1 2025, an estimated $763K.
Sivik Global Healthcare first reported a position in Maravai LifeSciences in Q3 2021 and held it in 6 quarters.
Sivik Global Healthcare's Maravai LifeSciences position peaked at $3.68M in Q3 2021.
184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Sivik Global Healthcare's 13F filing for Q1 2025, filed 22 Apr 2025.